Teleflex Incorporated recently announced that 100,000 patients have been treated globally with its minimally invasive UroLift System developed for men with Benign Prostatic Hyperplasia (BPH) or enlarged prostate, a life-disrupting condition that can cause a variety of adverse physical, mental and emotional symptoms.
“The vast majority of patients with BPH are under the impression that medication or invasive surgery are the only available options to treat their symptoms; however, more and more physicians are recommending the UroLift System treatment to their patients because it doesn’t carry the long-term side effects of other BPH treatments,” said Peter Walter, M.D., F.A.C.S., of Western New York Urology Associates in Jamestown, NY, in a prepared statement. “After treating men using the UroLift System and observing the positive outcomes in their symptom relief and overall quality of life, I chose the UroLift System as my own treatment for my BPH symptoms.”
The procedure claims to deliver fast relief from symptoms without causing any disruption to sexual functioning.
